C-type Lectin-Like Molecule-1 (Cll1)-Targeted TRAIL Augments the Tumoricidal Activity of Granulocytes and Potentiates Therapeutic Antibody-Dependent Cell-Mediated Cytotoxicity.
MABS（2015）
Key words
leukocyte,granulocyte,CLL1,TRAIL,ADCC,antibody-therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined